Diamonds and Dogs


Amgen (AMGN) wins a court case. The biotech giant is up 5% today after rallying 5% on Friday following a court case that went their way. The district court of New Jersey on Friday upheld the validity of its two patents on blockbuster rheumatoid arthritis drug Enbrel against Novartis' generic arm, Sandoz. The decision protects Amgen's Enbrel drug until 2029. If the decision had gone the other way, Amgen's opponent in the case, Novartis subsidiary, Sandoz could have launched a biosimilar version of Enbrel next year. An analyst at Cowen upgraded the stock with a $231 price target saying the stock could see multiple expansion.

Hong Kong protests not good for American luxury companies. Estee Lauder (EL) is down 3% along with Movado Group and Tiffany as protestors in Hong Kong shutdown the region's airport. Hong Kong is a major market for expensive consumer products, and the protests over the last 10 weekends, are disrupting retail businesses, travel, and gaming. The index of North America luxury goods has fallen nearly 30% since late April, when protests began.  

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.